USE OF INDUCER OF PROMYELOCYTIC LEUKEMIA PROTEIN (PML) FOR TREATING POLYGLUTAMINE EXPANSION NEURODEGENERATIVE DISEASES

摘要

The present invention relates to use of an inducer of Promyelocytic Leukemia protein (PML) expression, and especially PML IV for the manufacture of a medicament intended for the treatment of polyglutamine expansion neurodegenerative diseases. More specifically, the present invention relates to the use of an interferon polypeptide for the manufacture of a medicament intended for the treatment of polyglutamine expansion neurodegenerative diseases.